Home Tools
Log in
Cart

Search Result

Search Results for " bcrp "

20

Compounds

Cat No. Product Name Synonyms Targets
T83892 33-BCRP Inhibitor 33-Breast Cancer Resistance Protein Inhibitor
33-BCRP inhibitor is a compound that blocks the action of breast cancer resistance protein (BCRP), enhancing the susceptibility of mitoxantrone-resistant H460/MX20 lung cancer cells to the cytotoxic effects of mitoxantro...
T79353 P-gp/BCRP-IN-2
P-gp/BCRP-IN-2 (compound 15), an oxadiazole derivative, functions as a dual inhibitor targeting both the ABC transporter P-glycoprotein (IC50: 1.6 nM) and BCRP (IC50: 600 nM). Additionally, it bolsters the anti-prolifera...
T63267 P-gp/BCRP-IN-1
P-gp/BCRP-IN-1 (compound 19) is a relatively safe, orally active, and efficient inhibitor of the efflux transporters P-gp and BCRP. By inhibiting their efflux function, it reverses resistance and enhances the oral bioava...
TQ0186 Ko 143 BCRP , ABC
Ko 143 is a selective inhibitor of ATP-binding cassette sub-family G member 2 (ABCG2; BCRP).
T5778 5,7-DIMETHOXYFLAVONE Anti-infection , P450
5,7-DIMETHOXYFLAVONE possessed remarkable leishmanicidal potential.
T3581 KS176 Potassium Channel , BCRP
KS176 is a potent and selective inhibitor of the breast cancer resistance protein (BCRP) multidrug transporter, showing no inhibitory activity against P-gp or MRP1.
T4595 YHO-13177 YHO 13177,YHO13177 BCRP
YHO-13177 is a potent and specific inhibitor of BCRP; potentiated the cytotoxicity of SN-38 in cancer cells and no effect on P-glycoprotein–mediated paclitaxel resistance in MDR1-transduced human leukemia K562 cells.
T38400 Triclabendazole sulfoxide TCBZ-SO BCRP , Parasite
Triclabendazole sulfoxide (TCBZ-SO) is a main plasma metabolite of Triclabendazole. Triclabendazole sulfoxide inhibits membrane transporter ABCG2/BCRP and exhibits anti-parasite effects.
T8596 Ceefourin 1 MRP
Ceefourin 1 is a highly selective multidrug resistance protein 4 (MRP4) inhibitor.
T4337 PCI 29732 PCI29732,PCI-29732 Others , BCRP , BTK
PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.
T13383 Zamicastat BIA 5-1058 BCRP , Hydroxylase , P-gp
Zamicastat (BIA 5-1058) is an inhibitor of dopamine β-hydroxylase (DBH), and is also a concentration-dependent dual inhibitor of P-gp and BCRP(IC50 values of 73.8 μM and 17.0 μM, respectively).
T2657 Elacridar GW0918,GW120918,GF120918,GG918 BCRP , P-gp
Elacridar (GG918) (GF120918) is an effective BCRP and P-gp (MDR-1) inhibitor.
T15355 Fumitremorgin C 12α-Fumitremorgin C BCRP , Antibacterial , Antibiotic , ABC
Fumitremorgin C (12α-Fumitremorgin C) is a mycotoxin and inhibits ABCG2/BRCP.
TN3150 6,8-Diprenylnaringenin Senegalensin,Lonchocarpol A BCRP , ABC
6,8-Diprenylnaringenin (Senegalensin) is a natural product from hop Humulus lupulus. 6,8-Diprenylnaringenin is a breast cancer resistance protein(BCRP) inhibitor with some estrogenicity.
T13365 YHO-13351 free base BCRP
YHO-13351 free base is the water-soluble prodrug of YHO-13177 which is an inhibitor of BCRP .
T19649 PF-06273340 PF 6273340,PF 06273340,PF6273340,PF-6273340 Trk receptor
PF-06273340 is an effective, Selective, and Peripherally Restricted Pan-Trk inhibitor (IC50: Trk-A = 6 nM; Trk-B = 4 nM; Trk-C = 3 nM). PF-06273340 has low metabolic turnover in HLM and hHep is a good substrate for efflu...
T67821 GS-9191 PM BCRP , Antiviral
GS-9191 PM is a novel antitumorviral compound, a bis-amide prodrug of the nucleotide analog 9-(2-phosphonomethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine (cPrPMEDAP).GS-9191 PM is a potent inhibitor of MDR1 and BCRP.GS-91...
T16113 ML753286 AMPK
ML753286 has high permeability and low to medium clearance in rodent and human liver S9 fractions. ML753286 is an orally active and selective inhibitor of BCRP (IC50: 0.6 μM). It is also stable in plasma across species.
T10490 (S)-ML753286 Others
(S)-ML753286 is a breast cancer resistance protein (BCRP) inhibitor (IC50: 0.6 μM on BCRP efflux transporter).
T22680 CP-100356 hydrochloride CP-100356 HCl,CP 100356 hydrochloride BCRP
CP-100356 hydrochloride is an orally active and low micromolar dual inhibitor of MDR1 (P-gp) and BCRP, a nucleotide-derived substrate analogue with inhibitory effects on MDR1-mediated Calcein-AM transporter and BCRP-medi...
1 2
TargetMol